Acetylsalicylic acid placebo

DRUG2 trials

Sponsors

Centre Hospitalier Intercommunal Creteil, Bristol-Myers Squibb

Conditions

Acute Coronary SyndromesFetal growth restrictionPre-EclampsiaPregnancy associated hypertension

Phase 3

CHASAP : Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled trial.

RecruitingCTIS2024-516461-36-00

Centre Hospitalier Intercommunal CreteilFetal growth restriction, Pre-Eclampsia, Pregnancy associated hypertension

Start: 2021-01-27Target: 500Updated: 2024-10-17

Phase 4

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

CompletedNCT02415400

Bristol-Myers SquibbAcute Coronary Syndromes

Start: 2015-06-04End: 2018-11-10Updated: 2020-06-11

Related Papers

Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention

JACC Advances2025-03-212 citations

Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS.

2025-02-053 citations

Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS.

2024-11-17

Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial

Circulation Cardiovascular Interventions2024-11-011 citations

Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS.

2024-09-014 citations

Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke

JAMA Cardiology2022-05-258 citations

Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.

2022-02-0116 citations

Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

Open Heart2022-02-01

Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention

Circulation2021-01-1914 citations

A Matter of Timing: Antithrombosis Strategies Stratified by Time After ACS or PCI in Patients with Atrial Fibrillation

Journal watch2020-04-01

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention

Circulation2020-03-29128 citations

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention

Circulation2019-09-2669 citations

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

New England Journal of Medicine2019-03-171125 citations